18:04 , Oct 12, 2018 |  BC Week In Review  |  Financial News

First-day pop for Allogene after year's largest biotech IPO on NASDAQ

Less than a year after it was founded, cell therapy company Allogene Therapeutics Inc. (NASDAQ:ALLO) raised $324 million late Oct. 10 in the largest IPO by a biotech on NASDAQ thus far in 2018. The...
02:40 , Oct 11, 2018 |  BC Extra  |  Financial News

First-day pop for Allogene after year's largest biotech IPO on NASDAQ

Less than a year after it was founded, cell therapy company Allogene Therapeutics Inc. (NASDAQ:ALLO) raised $324 million late Wednesday in the largest IPO by a biotech on NASDAQ thus far in 2018. The company...
20:23 , Oct 5, 2018 |  BC Week In Review  |  Financial News

Allogene IPO could be year's largest biotech listing on NASDAQ

In newly proposed terms for its planned IPO on NASDAQ, cell therapy start-up Allogene Therapeutics Inc. (South San Francisco, Calif.) hopes to sell 16 million shares at $16-$18. At the midpoint, Allogene would raise $272...
22:58 , Oct 2, 2018 |  BC Extra  |  Financial News

Allogene IPO could be year's largest biotech listing on NASDAQ

In newly proposed terms for its planned IPO on NASDAQ, cell therapy start-up Allogene Therapeutics Inc. (South San Francisco, Calif.) hopes to sell 16 million shares at $16-$18. At the midpoint, Allogene would raise $272...
16:33 , Sep 21, 2018 |  BC Week In Review  |  Financial News

Ex-Kite execs prep quick IPO for CAR T play Allogene

Cell therapy start-up Allogene Therapeutics Inc. (South San Francisco, Calif.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan, Cowen and Jefferies. Launched in April with...
14:34 , Sep 14, 2018 |  BC Extra  |  Financial News

Ex-Kite execs prep quick IPO for CAR T play Allogene

Cell therapy start-up Allogene Therapeutics Inc. (South San Francisco, Calif.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan, Cowen and Jefferies. Launched in April with...
19:30 , Sep 7, 2018 |  BC Week In Review  |  Financial News

Allogene raises $120M in convertible notes

Just a few months after raising $300 million in a series A round, cell therapy company Allogene Therapeutics Inc. (South San Francisco, Calif.) raised $120 million through the sale of convertible notes. Perceptive Advisors led...
20:16 , Sep 6, 2018 |  BC Extra  |  Financial News

Allogene raises $120M in convertible notes

Just a few months after raising $300 million in a series A round, cell therapy company Allogene Therapeutics Inc. (South San Francisco, Calif.) raised $120 million through the sale of convertible notes. Perceptive Advisors led...
23:11 , Aug 28, 2018 |  BC Extra  |  Company News

Management tracks: BMS, Roche

Bristol-Myers Squibb Co. (NYSE:BMY) said Christopher Boerner will become EVP and Chief Commercial Officer. He succeeds Murdo Gordon, who departed the company last month to become EVP of global commercial operations at Amgen Inc. (NASDAQ:AMGN)...
22:04 , Aug 14, 2018 |  BC Extra  |  Company News

Management tracks: Cheng departing Gilead as CMO

Gilead Sciences Inc. (NASDAQ:GILD) said CMO Andrew Cheng will leave the company, effective Sept. 7, after five months in the role to pursue another opportunity. Gilead did not say who would replace Cheng, who joined...